Larotaxel
From Infogalactic: the planetary knowledge core
| File:Larotaxel.png | |
| Systematic (IUPAC) name | |
|---|---|
|
(2α,5β,7β,10β,13α)-4,10-Diacetoxy-1-hydroxy-13-{[(2R,3S)-2-hydroxy-3-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-3-phenylpropanoyl]oxy}-9-oxo-5,20-epoxy-7,19-cyclotax-11-en-2-yl benzoate
|
|
| Identifiers | |
| CAS Number | 156294-36-9  |
| ATC code | none |
| PubChem | CID: 6918260 |
| ChemSpider | 5293466  |
| UNII | TWQ8K8A81Y |
| Chemical data | |
| Formula | C45H53NO14 |
| Molecular mass | 831.90 g/mol |
| (what is this?) (verify) |
|
Larotaxel (code names XRP9881, RPR109881) is a drug of the taxane type that has been used experimentally in chemotherapy.[1]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Mitotic inhibitors
- Taxanes
- Antineoplastic and immunomodulating drug stubs
